The Rise of Z-Bound: A New Contender in Weight Loss Drugs

Rafal Trzaskowski, the liberal mayor expected to win the first round cleanly only squeaked by. We ask what’s at stake in the NATO-front-line country now the second round looks so uncertain. In the new world of weight-loss drugs Wegovy, from Novo Nordisk, has reigned supreme—perhaps not for much longer (9:40). And people really do look—but also act—like their dogs (16:51).

Get a world of insights by subscribing to Economist Podcasts+. For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.

Hosted on Acast. See acast.com/privacy for more information.